Azelastine Eye Drops in the Treatment of Seasonal Allergic Conjunctivitis or Rhinoconjunctivitis in Young Children

References

• Weeke E. R. Epidemiology of hayfever and perennial allergic rhinitis. Monogr. Allergy 1987; 21: 1–201. Weeke E. R. Epidemiology of hayfever and perennial allergic rhinitis. Monogr. Allergy 1987; 21: 1–20
   PubMedGoogle Scholar
• Friedlaender M. H., Ohashi Y., Kelley J. Diagnosis of allergic conjunctivitis. Arch. Ophthalmol 1984; 102: 1198–11992. Friedlaender M. H., Ohashi Y., Kelley J. Diagnosis of allergic conjunctivitis. Arch. Ophthalmol 1984; 102: 1198–1199
   PubMed Web of Science ®Google Scholar
• Friedlaender M. H. Conjunctivitis of allergic origin: clinical presentation and differential diagnosis. Sun'. Ophthalmol 1993; 38: 105–114, (Suppl)3. Friedlaender M. H. Conjunctivitis of allergic origin: clinical presentation and differential diagnosis. Sun'. Ophthalmol 1993; 38: 105–114, (Suppl)
   PubMed Web of Science ®Google Scholar
• Abelson M. B., Schaefer K. Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy. Surv. Ophthalmol. 1993; 38: 115–132, (Suppl)4. Abelson M. B., Schaefer K. Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy. Surv. Ophthalmol. 1993; 38: 115–132, (Suppl)
   PubMed Web of Science ®Google Scholar
• Ciprandi G., Buscaglia S., Canonica G. W. Management of allergic conjunctivitis. Clin. Immunother. 1996; 5: 374–3915. Ciprandi G., Buscaglia S., Canonica G. W. Management of allergic conjunctivitis. Clin. Immunother. 1996; 5: 374–391
   Google Scholar
• Janssens M. M.-L., Van Den Bussche G. Levocabastine: an effective topical treatment of allergic rhinoconjunctivitis. Clin. Exp. Allergy 1991; 21(Suppl. 2)29–366. Janssens M. M.-L., Van Den Bussche G. Levocabastine: an effective topical treatment of allergic rhinoconjunctivitis. Clin. Exp. Allergy 1991; 21(Suppl. 2)29–36
   PubMedGoogle Scholar
• Abelson M. B., Weintraub D. Levocabastine eye drops: a new approach for the treatment of acute allergic conjunctivitis. Eur. J. Ophthalmol 1994; 4: 91–1017. Abelson M. B., Weintraub D. Levocabastine eye drops: a new approach for the treatment of acute allergic conjunctivitis. Eur. J. Ophthalmol 1994; 4: 91–101
   PubMedGoogle Scholar
• Bahmer F. A. Topical levocabastine - an effective alternative to oral antihistamines in seasonal allergic rhinoconjunctivitis. Clin. Exp. Allergy 1995; 25: 220–2278. Bahmer F. A. Topical levocabastine - an effective alternative to oral antihistamines in seasonal allergic rhinoconjunctivitis. Clin. Exp. Allergy 1995; 25: 220–227
   PubMed Web of Science ®Google Scholar
• Odelram H., Bjorksten B., Afklercker T., Rimas M., Kjellman N.-I. M., Blychert L.-O. Topical levocabastine versus sodium cromoglycate in allergic conjunctivitis. Allergy 1989; 44: 432–4369. Odelram H., Bjorksten B., Afklercker T., Rimas M., Kjellman N.-I. M., Blychert L.-O. Topical levocabastine versus sodium cromoglycate in allergic conjunctivitis. Allergy 1989; 44: 432–436
   PubMed Web of Science ®Google Scholar
• Njaa E., Baekken T., Bjaamer D., Holme J. I., Korsrud F., Woxen O., Olsen A. K. Levocabastine compared with sodium cromoglycate eye drops in children with both birch and grass pollen allergy. Pediatr. Allergy Immunol 1992; 3: 39–4210. Njaa E., Baekken T., Bjaamer D., Holme J. I., Korsrud F., Woxen O., Olsen A. K. Levocabastine compared with sodium cromoglycate eye drops in children with both birch and grass pollen allergy. Pediatr. Allergy Immunol 1992; 3: 39–42
   Google Scholar
• Janssens M. M.-L. Levocabastine: a new topical approach for the treatment of pediatric allergic rhinoconjunctivitis. Rhinology 1992, Suppl 13: 39–4911. Janssens M. M.-L. Levocabastine: a new topical approach for the treatment of pediatric allergic rhinoconjunctivitis. Rhinology 1992, Suppl 13: 39–49
   Google Scholar
• McTavish D., Sorkin E. M. Azelastine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 1989; 38: 778–80012. McTavish D., Sorkin E. M. Azelastine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 1989; 38: 778–800
   PubMed Web of Science ®Google Scholar
• Lässig W., Wober W., Höflich C., Bähre M., Roloff A. Topical therapy of allergic rhinitis in childhood: Allergodil nasal spray - non-sedating in children. Curr. Med. Res. Opinion 1996; 13(7)391–39513. Lässig W., Wober W., Höflich C., Bähre M., Roloff A. Topical therapy of allergic rhinitis in childhood: Allergodil nasal spray - non-sedating in children. Curr. Med. Res. Opinion 1996; 13(7)391–395
   PubMed Web of Science ®Google Scholar
• Giede-Tuch C., Westhoff M., Zarth A. Azelastine eye drops in seasonal allergic conjunctivitis or rhinoconjunctivitis. Allergy 1998, accepted for publication14. Giede-Tuch C., Westhoff M., Zarth A. Azelastine eye drops in seasonal allergic conjunctivitis or rhinoconjunctivitis. Allergy 1998, accepted for publication
   PubMed Web of Science ®Google Scholar
• Lenhard G., Mivsek-Music E., Perrin-Fayolle M., Obtulowicz K., Secchi A. Double-blind, randomised, placebo-controlled study of two concentrations of azelastine eye drops in seasonal allergic conjunctivitis or rhinoconjunctivitis. Curr. Med. Res. Opinion 1997; 14(1)21–2815. Lenhard G., Mivsek-Music E., Perrin-Fayolle M., Obtulowicz K., Secchi A. Double-blind, randomised, placebo-controlled study of two concentrations of azelastine eye drops in seasonal allergic conjunctivitis or rhinoconjunctivitis. Curr. Med. Res. Opinion 1997; 14(1)21–28
   PubMed Web of Science ®Google Scholar
• Juniper E. F., Guyatt G. H. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin. Exp. Allergy 1991; 21: 77–8316. Juniper E. F., Guyatt G. H. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin. Exp. Allergy 1991; 21: 77–83
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services. Asthma and allergies: an optimistic future. DHHS publications No. NIH 80–388, DHHS, Bethesda 198017. US Department of Health and Human Services. Asthma and allergies: an optimistic future. DHHS publications No. NIH 80–388, DHHS, Bethesda 1980
   Google Scholar
• Ciprandi G., Buscaglia S., Catrullo A., Pesce G., Fiorino N., Montagna P., Bagnasco M., Canonica G. W. Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert antiallergic activity. Clin. Exp. Allergy 1997; 27: 182–19118. Ciprandi G., Buscaglia S., Catrullo A., Pesce G., Fiorino N., Montagna P., Bagnasco M., Canonica G. W. Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert antiallergic activity. Clin. Exp. Allergy 1997; 27: 182–191
   PubMed Web of Science ®Google Scholar
• Howarth P. H. A review of the tolerability and safety of levocabastine eye drops and nasal spray. Implications for patient management. Medial. Inflamm. 1995; 4: S26–S3019. Howarth P. H. A review of the tolerability and safety of levocabastine eye drops and nasal spray. Implications for patient management. Medial. Inflamm. 1995; 4: S26–S30
   PubMed Web of Science ®Google Scholar
• Giede-Tuch C., Metzenauer P. Investigation of the efficacy and tolerability of azelastine, levocabastine and placebo eye drops in patients with seasonal allergic conjunctivitis. Allergy 1997; 52(Suppl 37)19920. Giede-Tuch C., Metzenauer P. Investigation of the efficacy and tolerability of azelastine, levocabastine and placebo eye drops in patients with seasonal allergic conjunctivitis. Allergy 1997; 52(Suppl 37)199
   Google Scholar